Discover investment opportunities in Stocks Less Than $10 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Less Than $10 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Less Than $10 using our Smart AI Filter.
9 stocks found for "Stocks Less Than $10"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.21 | ±56.5% | -86.3 | 0.00% | |||
0.65 | ±52.7% | 7.9 | 4.57% | |||
1.07 | ±57.3% | 64.0 | 0.00% | |||
1.20 | ±100.0% | -1.6 | 0.00% | |||
1.20 | ±100.0% | 0.0 | 0.00% | |||
1.36 | ±73.8% | 285.9 | 0.00% | |||
0.73 | ±83.1% | — | 0.00% | |||
2.23 | ±99.6% | 441.5 | 0.00% | |||
0.61 | ±38.9% | 6.7 | 5.08% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Read moreCommerce Secretary Howard Lutnick said Tuesday that the Trump administration is considering buying ownership stakes in major defense contractors, similar to its recent controversial move to acquire part of chipmaker Intel Corp. INTC.
Read moreAfter reaching an important support level, Ginkgo Bioworks Holdings, Inc. (DNA) could be a good stock pick from a technical perspective. DNA surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend.
Read moreQ: Why might "HBI" be appealing for value investors?
A: HBI (Hanesbrands Inc.) trades below $10, making it potentially attractive to value investors. These investors could be drawn to low P/E ratios or the company's strategic initiatives, such as cost reduction plans or brand recognition in the global apparel market. However, they must assess the company's debt levels and any shifts in consumer trends.
Q: How do economic downturns impact "GNW"?
A: GNW (Genworth Financial) is sensitive to economic cycles due to its focus on insurance and asset management. During downturns, demand for new insurance policies may decline, and asset values might drop, affecting their portfolio. Historical performance has shown variable resilience in such periods, warranting careful monitoring.
Q: What growth opportunities exist for "F"?
A: F (Ford Motor Company) under $10 offers growth potential via its expansion into electric vehicles. The company invests significantly in this sector, aiming to rival existing EV leaders. Its strategic alliances and technological innovations hold promise, although competition and regulatory factors remain significant challenges.
Q: How does "BBBYQ"'s bankruptcy status affect investment risks?
A: BBBYQ (Bed Bath & Beyond Inc.) is in bankruptcy proceedings, drastically elevating investment risk. Investors face the prospect of limited or no returns due to asset liquidation priorities favoring creditors. Recovery value for shareholders is uncertain and requires thorough consideration of court rulings and liquidation values.
Q: What sector-specific challenges does "KIRK" face?
A: KIRK (Kirkland's Inc.) in the home decor retail sector faces challenges like changing consumer preferences, online competition, and supply chain disruptions. These factors can impact financial performance adversely, despite any existing competitive pricing or uniquely curated product lines.
Q: How viable is "NBY" for biotech investors?
A: NBY (NovaBay Pharmaceuticals) presents prospects for biotech investors interested in emerging, small-cap companies. While potential approval of new products could boost growth, regulatory hurdles, limited resources, and market competition all pose significant risks. Detailed research into the company's pipeline is advisable.